Sign up
Pharma Capital
Market: ASX
52-week High/Low: A$0.88 / A$0.16
Sector: Pharma & Biotech
Market Cap: A$14.82M
Anatara Lifesciences (ASX:ANR) is developing and commercialising products for gastrointestinal health.

Anatara Lifesciences Ltd

Interactive graph

col 3
col 4
col 5
col 6

Anatara Lifesciences Ltd Snapshot

View full ANR profile View Profile
View All

Executive video interviews


© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.